Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
11/2010
11/18/2010WO2010130383A1 Monoazo compounds
11/18/2010WO2010130382A1 Bisazo compounds
11/18/2010WO2010130178A1 Acrylamide derivative and use thereof in manufacture of medicament
11/18/2010WO2010130034A1 Inhibitors of human immunodeficiency virus replication
11/18/2010WO2010103297A3 Bis aromatic compounds for use as ltc4 synthase inhibitors
11/18/2010WO2010102824A3 Sodium salt of 5-cyclopropyl-2-{[2-(2,6- difluorophenyl)pyrimidin-5-yl]amino}benzoic acid as dhodh inhibitor
11/18/2010WO2010077798A3 Stereoselective synthesis of piperidine derivatives
11/18/2010WO2010059611A3 Inhibitors of diacylglycerol acyltransferase
11/18/2010WO2010033168A3 Modulators of p2x3 receptor activity
11/18/2010US20100292500 Npy y5 antagonist
11/18/2010US20100292485 Process for the preparation of a 2-pyridylethylcarboxamide derivative
11/18/2010US20100292482 Novel precursors
11/18/2010US20100292478 Process of preparing a radioactive compound containing a fluorine-18 isotope
11/18/2010US20100292472 Prophylactic and therapeutic medicine for malaria
11/18/2010US20100292279 Bis-(Sulfonylamino) Derivatives in Therapy
11/18/2010US20100292239 Novel microbiocides
11/18/2010US20100292229 Tryphostin-analogs for the treatment of cell proliferative diseases
11/18/2010US20100292215 11beta-hydroxysteroid dehydrogenase type 1 active compounds
11/18/2010US20100288634 Transition Metal Complexes with Bidentate Ligand Having an Imidazole Ring
11/18/2010US20100287714 Dye composition containing a thiol/disulphide fluorescent dye comprising amino groups and comprising an internal cationic charge, process for lightening keratin materials using this dye
11/18/2010CA2762036A1 Inhibitors of human immunodeficiency virus replication
11/18/2010CA2761859A1 Aryl pyridine as aldosterone synthase inhibitors
11/17/2010EP2251333A1 Biphenyl derivatives as P-38 kinase inhibitors
11/17/2010EP2251329A1 Process for production of 3-amino-2-chloro-6- trifluoromethylpyridine
11/17/2010EP2251328A1 Crystalline 1-(3-fluorophenyl)-5-methyl-2-(1h)pyridone, the preparation methods, compositions and applications thereof
11/17/2010EP2251327A2 Heterocyclic inhibitors of MEK and methods of use thereof
11/17/2010EP2251324A1 Heteroaryl-alkylcarbamate compounds and their use as inhibitors of the faah enzyme
11/17/2010EP2249650A1 Anilinopyridines as inhibitors of fak
11/17/2010EP2170260B1 Azo derivatives containing a pyrazolinone unit for dyeing keratin fibres
11/17/2010EP1797035B1 Cyclopropyl piperidine glycine transporter inhibitors
11/17/2010EP1476428B1 Pyridyl sulfone derivatives as 5-ht6 receptor ligands
11/17/2010EP1032377B1 Substituted 2-aminoacetamides and the use thereof
11/17/2010CN101888999A Pyridylmethyl-sulfonamide compounds
11/17/2010CN101888998A Oxime ether derivative and bactericide for agricultural and horticultural use
11/17/2010CN101888989A Novel aryl potassium channel blockers and uses thereof
11/17/2010CN101888877A Pyridine derivatives for the treatment of amyloid-related diseases
11/17/2010CN101885703A N-oxyaryloxyphenoxy carboxylic acid amide compound with bioactivity and preparation method thereof
11/17/2010CN101885702A Method for synthesizing 3,5,6-trichloropyridin 2 ol sodium by liquid-phase normal-pressure buffer solution method
11/17/2010CN101885653A Synthesis method of N-heteroaryl amino acid
11/16/2010US7834183 producing pyridine-substituted indole compound by reacting an indole with pyridine having leaving group, in presence of heterogeneous-system platinum group metal catalyst on support, ligand (1,1'-bis(diphenylphosphino)ferrocene) and base; industrial scale, cost efficiency
11/16/2010US7834062 Aminoalkylphenols, methods of using and making the same
11/16/2010US7834054 Hydroxamates as therapeutic agents
11/16/2010US7834043 Prevent reproduct of aids virus
11/16/2010US7834013 Racemic-(trans)-2-[4-({[3-(phenyloxy)phenyl]methyl}ammonium)phenyl]cyclopropanecarboxylic acid; type II diabetes; G protein-coupled receptor 40 (GPR40) agonists
11/16/2010CA2427548C Heteroarylacryloylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical preparations comprising them
11/11/2010WO2010129802A1 Inhibitors of jak
11/11/2010WO2010129570A1 Solid forms of sulfonamides and amino acids
11/11/2010WO2010127928A1 Insecticidal compounds
11/11/2010WO2010127440A1 Substituted aromatic compounds and pharmaceutical uses thereof
11/11/2010WO2009143178A3 Pde10 inhibitors and related compositions and methods
11/11/2010US20100286215 Bis-aromatic compounds useful in the treatment of inflammation
11/11/2010US20100286206 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones
11/11/2010US20100286164 Substituted aryl alkylamino-oxy-analogs and uses thereof
11/11/2010US20100286146 Carboxamide compounds and their use as calpain inhibitors
11/11/2010CA2761018A1 Substituted aromatic compounds and pharmaceutical uses thereof
11/11/2010CA2759592A1 Insecticidal compounds
11/10/2010EP2248423A1 Composition for agricultural use for controlling or preventing plant diseases caused by plant pathogens
11/10/2010EP2247576A1 Inhibitors for brassinosteroid signalling
11/10/2010EP2114888B1 Tricyclic compounds and their use as glucocorticoid receptor modulators
11/10/2010EP2052252B1 Luminescent lanthanide labelling reagents and their use
11/10/2010CN1946693B Therapeutic formulations of desoxyepothilones
11/10/2010CN1918134B Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cyto kine inhibitors
11/10/2010CN1824654B Pyrithione metal salts having defined particle size distribution and paint composition containing the same
11/10/2010CN101883760A Heteroaryl amides useful as inhibitors of voltage-gated sodium channels
11/10/2010CN101883759A 2-substituted-6-amino-5-alkyl, alkenyl or alkynyl-4-pyrimidinecarboxylic acids and 6-substituted-4-amino-3-alkyl, alkenyl or alkynyl picolinic acids and their use as herbicides
11/10/2010CN101883758A Aryl amides useful as inhibitors of voltage-gated sodium channels
11/10/2010CN101883757A Method for producing 6-halogeno-3-arylpyridine derivative
11/10/2010CN101880258A Method for synthesizing 3, 5, 6-trichloropyridine natrium phenolicum by liquid-phase normal-pressure organic solvent method
11/10/2010CN101293868B Process for synthesizing D-alpha-(6-methyl-4-hydroxyl nicotinamide base)p-hydroxyphenylacetic acid
11/10/2010CN101039902B Aminoalcohol derivatives
11/09/2010US7829721 Therapy for diabetic retinopathy
11/09/2010US7829720 Process for preparing atazanavir bisulfate and novel forms
11/09/2010US7829613 Azinium salts as splayant for layered materials
11/09/2010US7829597 preventing the formation of insoluble A beta and arresting the production of A beta; beta-site amyloid precursor protein-cleaving enzyme; 3-[(2-amino-2-methyl-3-phenylpropoxy)methyl]-N-[(1R)-1-(4-fluorophenyl)ethyl]-[methyl(methylsulfonyl)amino]benzamide
11/09/2010US7829587 adrenergic receptor agonists such as (8-Methoxy-1,2,3,4-tetrahydro-naphthalen-2-yl)-propyl-pyridin-4-ylmethyl-amine, used as analgesics, decongestants, antidepressants and anxiolytic agents or for the treatment of vision defects, neurodegenerative diseases, diarrhea, attention deficit disorder, psychoses
11/09/2010US7829584 thrombin inhibitors such as 3-cyano-6-(2,2-difluoro-2-phenyl-ethylamino)-2-{2-[(aminoiminomethyl)aminooxy]ethyl}aminocarbonylmethyl-pyridine-1-oxide, used for the prophylaxis or treatment of diseases and conditions related to thrombin activity in mammals
11/09/2010US7829564 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/09/2010US7829560 such as N-(4-{[2-(4-Ethylpiperazin-1-yl)pyrimidin-4-yl]oxy}-1-naphthyl)-3-fluoro-5-piperidin-1-ylbenzamide, useful as antiproliferative agents or in treating arthritis, osteoarthritis, Crohn's disease, ulcerative colitis, inflammatory bowel disease, psoriasis, autoimmune or inflammatory diseases
11/09/2010US7829341 Polyviologen boronic acid quenchers for use in analyte sensors
11/09/2010CA2453623C 6-aryl-4-aminopicolinates and their use as herbicides
11/09/2010CA2434937C Phenyl derivatives
11/04/2010WO2010126914A1 Pyridinone antagonists of alpha-4 integrins
11/04/2010WO2010126811A1 Cxcr3 receptor antagonists
11/04/2010WO2010125923A1 Polymer-supported catalyst and method for producing aromatic hetero compound using the catalyst
11/04/2010WO2010125831A1 Sulfamoyl benzoic acid derivatives as trpm8 antagonists
11/04/2010WO2010059503A3 PROCESS FOR MAKING (R) -3-(2,3-DIHYDROXYPROPYL)-6-FLUORO-5-(2-FLOURO-4-IODOPHENYLAMINO)-8-METHYLPYRIDO[2,3-d]PYRIMIDINE-4,7(3H,8H)-DIONE AND INTERMEDIATES THEREOF
11/04/2010WO2008148747A8 Pdz domain modulators
11/04/2010US20100280253 Production method of 6-halogeno-3-arylpyridine derivative
11/04/2010US20100280252 Poly(ethylene glycol) containing chemically disparate endgroups
11/04/2010US20100280248 Novel compounds that are useful for improving pharmacokinetics
11/04/2010US20100280081 Anti-inflammatory agents as virostatic compounds
11/04/2010US20100280075 Paclitaxel enhancer compounds
11/04/2010US20100280074 Ccr9 inhibitors and methods of use thereof
11/04/2010US20100280018 Derivatives Of Hydroxamic Acid As Metalloproteinase Inhibitors
11/04/2010US20100279340 Imaging agents for protein misfolding
11/04/2010US20100278733 Composition for diagnosis of amyloid-related disease
11/04/2010CA2760151A1 Pyridinone antagonists of alpha-4 integrins
11/04/2010CA2757761A1 Sulfamoyl benzoic acid derivatives as trpm8 antagonists
11/03/2010EP2246329A1 4(1H)-pyridinone derivatives and their use as antimalaria agents
11/03/2010EP2246038A1 Azomethinic cationic pyrazolidine derivatives for dyeing keratin fiber